Anja Mühlfeld
Universitätsklinikum Aachen(DE)
Publications by Year
Research Areas
Renal Transplantation Outcomes and Treatments, Complement system in diseases, Renal Diseases and Glomerulopathies, Organ Transplantation Techniques and Outcomes, Organ Donation and Transplantation
Most-Cited Works
- → BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy(2010)227 cited
- → The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment(2020)208 cited
- → Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study(2013)135 cited
- → Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study(2014)126 cited
- → Hemodialysis-Induced Release of Hemoglobin Limits Nitric Oxide Bioavailability and Impairs Vascular Function(2010)118 cited
- → Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura(2020)114 cited
- → Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study(2012)84 cited
- → ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP(2020)73 cited
- → Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation(2019)68 cited
- → Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults(2021)64 cited